These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22104352)

  • 1. Experimental characterization of the dosimetric properties of a newly designed I-Seed model AgX100 ¹²⁵I interstitial brachytherapy source.
    Chen Z; Bongiorni P; Nath R
    Brachytherapy; 2012; 11(6):476-82. PubMed ID: 22104352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer gel dosimetry for the TG-43 dosimetric characterization of a new 125I interstitial brachytherapy seed.
    Papagiannis P; Pantelis E; Georgiou E; Karaiskos P; Angelopoulos A; Sakelliou L; Stiliaris S; Baltas D; Seimenis I
    Phys Med Biol; 2006 Apr; 51(8):2101-11. PubMed ID: 16585848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the (125)I I-Seed AgX100 source model.
    Mourtada F; Mikell J; Ibbott G
    Brachytherapy; 2012; 11(3):237-44. PubMed ID: 21816684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near-field dosimetry of 125I sources for interstitial brachytherapy implants measured using thermoluminescent sheets.
    Iwata K; Yue NJ; Nath R
    Med Phys; 2004 Dec; 31(12):3406-16. PubMed ID: 15651623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A photon spectrometric dose-rate constant determination for the Advantage Pd-103 brachytherapy source.
    Chen ZJ; Bongiorni P; Nath R
    Med Phys; 2010 Feb; 37(2):672-4. PubMed ID: 20229876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photon energy spectrum emitted by a novel polymer-encapsulated 103Pd source and its effect on the dose rate constant.
    Khan S; Chen ZJ; Nath R
    Med Phys; 2008 Apr; 35(4):1403-6. PubMed ID: 18491535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
    Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
    Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
    Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the development of consensus values of reference dosimetry parameters for interstitial brachytherapy sources.
    Chan GH; Nath R; Williamson JF;
    Med Phys; 2004 May; 31(5):1040-5. PubMed ID: 15191290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed Model 6733 (125)I brachytherapy source.
    Sowards KT; Meigooni AS
    Brachytherapy; 2002; 1(4):227-32. PubMed ID: 15062171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source.
    Moutsatsos A; Pantelis E; Papagiannis P; Baltas D
    Brachytherapy; 2014; 13(6):618-26. PubMed ID: 25108795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.
    Meigooni AS; Hayes JL; Zhang H; Sowards K
    Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermoluminescent and Monte Carlo dosimetry of IR06-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Hosseini SH; Tenreiro C
    J Appl Clin Med Phys; 2011 Nov; 12(4):3581. PubMed ID: 22089014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetry for 131Cs and 125I seeds in solid water phantom using radiochromic EBT film.
    Chiu-Tsao ST; Napoli JJ; Davis SD; Hanley J; Rivard MJ
    Appl Radiat Isot; 2014 Sep; 92():102-14. PubMed ID: 25038559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TG-43 U1 based dosimetric characterization of model 67-6520 Cs-137 brachytherapy source.
    Meigooni AS; Wright C; Koona RA; Awan SB; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Oct; 36(10):4711-9. PubMed ID: 19928102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo dosimetric parameter study of a new (32)P brachytherapy source.
    Wu J; Huang J; Long F; Wang C; Wu Z; Gou C
    Br J Radiol; 2016 Jun; 89(1062):20150783. PubMed ID: 27042802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.